Cutaneous and Gastrointestinal Leukocytoclastic Vasculitis Induced by Palbociclib in a Metastatic Breast Cancer Patient: A Case Report

被引：9
作者：
Guillemois, Sylvere [1 ]
Patsouris, Anne [1 ]
Peyraga, Guillaume [2 ]
Chassain, Kevin [3 ]
Le Corre, Yannick [3 ]
Campone, Mario [1 ]
Augereau, Paule [1 ]
机构：
[1] Ctr Paul Papin, Med Oncol Dept, Inst Cancerol Ouest, Angers, France
[2] Ctr Paul Papin, Radiat Therapy Dept, Inst Cancerol Ouest, Angers, France
[3] Univ Hosp Angers, Dermatol Dept, Angers, France
来源：
CLINICAL BREAST CANCER | 2018年 / 18卷 / 05期
关键词：
Cyclin-dependent kinase 4/6 inhibitor; Drug-induced vasculitis; Faslodex; Fulvestrant; Ibrance; Vasculitis treatment; RANDOMIZED CONTROLLED-TRIAL; THERAPY; LETROZOLE;
D O I：
10.1016/j.clbc.2018.07.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The efficacy and safety of palbociclib, a cyclindependent kinase 4/6 inhibitor, used in combination with fulvestrant was assessed in women with advanced breast cancer (ABC) whose disease had progressed during previous endocrine therapy, with a significant improvement of progression-free survival and good health-related quality of life. We report a case of an 80-year-old patient with ABC who presented a cutaneous and gastrointestinal vasculitis during treatment with palbociclib and fulvestrant. The skin biopsy was consistent with a leukocytoclastic vasculitis with immunoglobulin A deposits in dermal blood vessels. The symptoms disappeared with the arrest of palbociclib and fulvestrant treatment and a high dose corticotherapy. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码：E755 / E758
页数：4
相关论文
共 50 条
  • [1] Sibutramine (Reductil®)-Induced Cutaneous Leukocytoclastic Vasculitis: A Case Report
    Ha, You Jin
    Han, You Jin
    Choi, You Won
    Myung, Ki Bum
    Choi, Hae Young
    ANNALS OF DERMATOLOGY, 2011, 23 (04) : 544 - 547
  • [2] Palbociclib-Induced Thrombotic Microangiopathy in Metastatic Breast Cancer Patient Surviving for 18 Years: Case Report and Review of the Literature
    Raiss, Hanan
    Peron, Julien
    Tartas, Sophie
    Trillet-Lenoir, Veronique
    Freyer, Gilles
    Errihani, Hassan
    CLINICAL BREAST CANCER, 2018, 18 (03) : E263 - E266
  • [3] Tofacitinib Treatment of Refractory Cutaneous Leukocytoclastic Vasculitis: A Case Report
    Zhu, Kai-Jun
    Yang, Pei-Dan
    Xu, Qiang
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [4] Adalimumab-induced leukocytoclastic vasculitis in a patient with ankylosing spondylitis: A case report
    Khabbazi, Alireza
    Hajialilo, Mehrzad
    Tekantapeh, Sepideh Tahsini
    Tabrizi, Sahar Farshchi
    Salehi, Alireza
    CLINICAL CASE REPORTS, 2024, 12 (08):
  • [5] Methimazole-Induced Leukocytoclastic Vasculitis: A Case Report
    Tawanwongsri, Weeratian
    Chayavichitsilp, Pamela
    CASE REPORTS IN DERMATOLOGY, 2019, 11 (03): : 303 - 309
  • [6] Complete Response to Single-agent Palbociclib in Metastatic Breast Cancer: A Case Report
    Yeruva, Sri Lakshmi Hyndavi
    Javadi, Mehrbod Som
    Stearns, Vered
    CLINICAL BREAST CANCER, 2018, 18 (03) : E277 - E280
  • [7] Amiodarone-Induced Leukocytoclastic Vasculitis in a Decompensated Heart Failure Patient: A Case Report
    Asfeen, Ummul
    Raj, Rohan
    Ezeafulukwe, Chinedu J.
    Hassan, Omar A.
    Francis, Deepa Treesa
    Dhillon, Sukhmeet S.
    Khan, Aadil
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [8] Sarcoidosis-like reaction during palbociclib treatment for metastatic breast cancer: A case report
    Stoffaes, Louis
    Dumazet, Antoine
    Deslee, Gaetan
    Muttaqi, Zulaid Mohammad
    Didier, Kevin
    Botsen, Damien
    BREAST JOURNAL, 2020, 26 (06) : 1239 - 1241
  • [9] Levamisole-induced myopathy and leukocytoclastic vasculitis: a case report and literature review
    Tsai, Meng-Hsuan
    Yang, Jen-Hung
    Kung, Sheng-Ling
    Hsiao, Yu-Ping
    DERMATOLOGIC THERAPY, 2013, 26 (06) : 476 - 480
  • [10] The safety and efficacy of palbociclib in the treatment of metastatic breast cancer
    Ettl, Johannes
    Harbeck, Nadia
    EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (08) : 661 - 668
12345